Canadian Drugmaker Apotex Seeks Up To $730 Million In First-Half IPO
An Apotex facility in Toronto, Ontario, Canada, on Friday, Feb. 27, 2026. Canadian generic drug manufacturer Apotex Inc. is looking at the first half of the year for an initial public offering in Toronto that could raise as much as C$1 billion ($730 million), according to people familiar with the matter. Photographer: Cole Burston/Bloomberg via Getty Images
PURCHASE A LICENSE
How can I use this image?
€300.00
EUR
Getty ImagesCanadian Drugmaker Apotex Seeks Up To $730 Million In First-Half IPO, News Photo
Canadian Drugmaker Apotex Seeks Up To $730 Million In First-Half IPO Get premium, high resolution news photos at Getty ImagesProduct #:2263890095
Canadian Drugmaker Apotex Seeks Up To $730 Million In First-Half IPO Get premium, high resolution news photos at Getty ImagesProduct #:2263890095€475€115
Getty Images
In stockDETAILS
Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Editorial #:
2263890095
Collection:
Bloomberg
Date created:
February 27, 2026
Upload date:
License type:
Release info:
Not released.ÌýMore information
Source:
Bloomberg
Object name:
CANADA APOTEX
Max file size:
5346 x 8015 px (17.82 x 26.72 in) - 300 dpi - 10 MB